NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0479887/Immuno-Chemistry-Reagents-Analyzers-and-Test-Kits---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html

Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global immunochemistry market. The report provides market landscape, competitive landscape and market trends information on the immunochemistry market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include disease specific immunochemistry, drugs of abuse/toxicology, therapeutic drug monitoring, endocrinology tests, immunochemistry analyzers, immunochemistry rapid tests, organ function assays and specific proteins.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company share data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within immunochemistry market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Roche, Siemens Healthcare and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the immunochemistry market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the immunochemistry market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global immunochemistry market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction and Overview 8

2.1 GlobalData Report Guidance 8

3 Immunochemistry Overview 9

3.1 Disease Specific Immunochemistry 9

3.1.1 Allergy Blood Tests 9

3.1.2 Auto-immune Diseases 9

3.1.3 Cardiac Markers 9

3.1.4 Rheumatoid – Inflammatory Diseases Markers 9

3.1.5 Tumor Markers 9

3.2 Drugs of Abuse/Toxicology 10

3.2.1 Drugs of Abuse 10

3.2.2 Toxicology 10

3.3 Therapeutic Drug Monitoring 10

3.3.1 Antibiotic TDM/Antivirus TDM 10

3.3.2 Cardiovascular TDM 10

3.3.3 Central Nervous Systems TDM 10

3.3.4 Immunosuppressant TDM 11

3.4 Endocrinology Tests 11

3.4.1 Fertility or Pregnancy Hormones 11

3.4.2 Individual and Specified Hormones 11

3.4.3 Thyroid Function Hormones 11

3.5 Immunochemistry Analyzers 12

3.5.1 Chemiluminescence Analyzers 12

3.5.2 ELISA Instruments 12

3.5.3 Immunofluorescence Analyzers 12

3.5.4 Radioimmunoassay Analyzers 12

3.6 Immunochemistry Rapid Tests 12

3.7 Organ Function Assays 12

3.8 Specific Proteins 12

4 Immunochemistry: Global Market Characterization 13

4.1 Immunochemistry Market, Global, Revenue ($m), Historic, 2003–2010 13

4.2 Immunochemistry Market, Global, Revenue ($m), Forecast, 2010–2017 14

4.3 Immunochemistry, Market Dynamics 15

4.3.1 Trends 15

4.3.2 Market Drivers 16

4.3.3 Market Restraints 21

5 Immunochemistry Market: Segment Analysis 23

5.1 Disease Specific Immunochemistry Market, Global, Revenue ($m), Historic, 2003–2010 23

5.2 Disease Specific Immunochemistry Market, Global, Revenue ($m), Forecast, 2010–2017 24

5.3 Disease Specific Immunochemistry, Market Dynamics 25

5.3.1 Market Drivers 25

5.3.2 Market Restraint: Bottlenecks in the Development of New Biomarkers Impeding the Development of Disease Specific Tests 25

5.4 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Historic, 2003–2010 26

5.5 Drugs of Abuse/Toxicology Market, Global, Revenue ($m), Forecast, 2010–2017 27

5.6 Drugs of Abuse/Toxicology, Market Dynamics 28

5.6.1 Market Drivers 28

5.6.2 Market Restraint: Developments in Testing Not Able to Match the Pace at Which Illegal Drugs are Being Invented 29

5.7 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Historic, 2003–2010 30

5.8 Therapeutic Drug Monitoring Market, Global, Revenue ($m), Forecast, 2010–2017 31

5.9 Therapeutic Drug Monitoring, Market Dynamics 32

5.9.1 Market Driver: High Awareness among Physicians with Regard to Available Diagnostic Options 32

5.9.2 Market Restraint: Lack of Medical History Records of Individuals in Underdeveloped Countries adversely affecting use of Therapeutic Drug Monitoring 32

5.10 Endocrinology Tests Market, Global, Revenue ($m), Historic, 2003-2010 33

5.11 Endocrinology Tests Market, Global, Revenue ($m), Forecast, 2010 – 2017 34

5.12 Endocrinology Tests, Market Dynamics 35

5.12.1 Market Driver: Surge in Reported Infertility Cases to Boost Testing Procedures 35

5.12.2 Market Restraint: Lack of Outreach about Options in Non-White Communities 35

5.13 Immunochemistry Analyzers Market, Global, Revenue ($m), Historic, 2003–2010 36

5.14 Immunochemistry Analyzers Market, Global, Revenue ($m), Forecast, 2010–2017 37

5.15 Immunochemistry Analyzers, Market Dynamics 38

5.15.1 Market Driver: Accuracy offered by Analyzers is leading to their Higher Adoption 38

5.15.2 Market Restraint: Competition from Rapid Tests 38

5.16 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Historic, 2003–2010 39

5.17 Immunochemistry Rapid Tests Market, Global, Revenue ($m), Forecast, 2010–2017 40

5.18 Immunochemistry Rapid Tests, Market Dynamics 41

5.18.1 Market Driver: High Demand from Emergency Departments for Faster Testing Results 41

5.18.2 Market Restraint: Diagnostic Laboratories not in Favor of Rapid Tests Usage 41

5.19 Organ Function Assays Market, Global, Revenue ($m), Historic, 2003–2010 42

5.20 Organ Function Assays Market, Global, Revenue ($m), Forecast, 2010–2017 43

5.21 Organ Function Assays, Market Dynamics 44

5.21.1 Market Driver: Increasing Incidences of Liver and Kidney Diseases and Availability of Numerous Testing Options to Boost Market Growth 44

5.21.2 Market Restraint: High Cost Associated with the Overall Testing Discouraging People from Undergoing Tests 44

5.22 Specific Proteins Market, Global, Revenue ($m), Historic, 2003–2010 45

5.23 Specific Proteins Market, Global, Revenue ($m), Forecast, 2010–2017 46

5.24 Specific Proteins, Market Dynamics 47

5.24.1 Market Driver: Use of Specific Protein Tests as the First Step in Diagnostics Boosting their Demand 47

5.24.2 Market Restraint: Lack of Knowledge about Proteins that are Specific to Each Disorder Affecting Development of Tests 47

6 Global Immunochemistry Market, by Country, Revenue ($m), 2003–2017 48

6.1 Immunochemistry Market, the US, Revenue ($m), Historic, 2003–2010 48

6.2 Immunochemistry Market, the US, Revenue ($m), Forecast, 2010–2017 49

6.3 Immunochemistry Market, Canada, Revenue ($m), Historic, 2003 –2010 50

6.4 Immunochemistry Market, Canada, Revenue ($m), Forecast, 2010–2017 51

6.5 Immunochemistry Market, the UK, Revenue ($m), Historic, 2003–2010 52

6.6 Immunochemistry Market, the UK, Revenue ($m), Forecast, 2010–2017 53

6.7 Immunochemistry Market, Germany, Revenue ($m), Historic, 2003–2010 54

6.8 Immunochemistry Market, Germany, Revenue ($m), Forecast, 2010–2017 55

6.9 Immunochemistry Market, France, Revenue ($m), Historic, 2003–2010 56

6.10 Immunochemistry Market, France, Revenue ($m), Forecast, 2010–2017 57

6.11 Immunochemistry Market, Italy, Revenue ($m), Historic, 2003–2010 58

6.12 Immunochemistry Market, Italy, Revenue ($m), Forecast, 2010–2017 59

6.13 Immunochemistry Market, Spain, Revenue ($m), Historic, 2003–2010 60

6.14 Immunochemistry Market, Spain, Revenue ($m), Forecast, 2010–2017 61

6.15 Immunochemistry Market, Japan, Revenue ($m), Historic, 2003–2010 62

6.16 Immunochemistry Market, Japan, Revenue ($m), Forecast, 2010–2017 63

6.17 Immunochemistry Market, China, Revenue ($m), Historic, 2003–2010 64

6.18 Immunochemistry Market, China, Revenue ($m), Forecast, 2010–2017 65

6.19 Immunochemistry Market, India, Revenue ($m), Historic, 2003–2010 66

6.20 Immunochemistry Market, India, Revenue ($m), Forecast, 2010–2017 67

6.21 Immunochemistry Market, Australia, Revenue ($m), Historic, 2003–2010 68

6.22 Immunochemistry Market, Australia, Revenue ($m), Forecast, 2010–2017 69

6.23 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2003–2010 70

6.24 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2010–2017 71

7 Global Immunochemistry Market: Strategic Competitive Assessment 72

7.1 Immunochemistry: Key Market Participants 73

7.1.1 F. Hoffmann-La Roche Ltd. 73

7.1.2 Siemens Healthcare 77

7.1.3 Abbott Laboratories 81

7.1.4 Alere Inc. 85

8 Global Immunochemistry Market: Product Pipeline Assessment 88

8.1 Profiles of Promising Immunochemistry Products under Clinical Development 88

8.1.1 PROGENSA PCA3 Assay 88

8.1.2 CertNDx Bladder Cancer Assay 90

8.1.3 ADVIA Centaur CP System – UE3 Assay 92

8.1.4 Access BPHA Assay 92

8.1.5 Dimension Vista 1500 Intelligent Lab System CA 15-3 Assay 93

8.1.6 Next Generation FIT for Colorectal Cancer 93

8.1.7 RealTime mS9 Colorectal Cancer Test 93

8.1.8 TheraScreen K-RAS Mutation Test 94

8.1.9 AMIPredict 94

9 Global Immunochemistry Market: Strategic Deals Analysis 95

9.1 Key Acquisitions 95

9.1.1 Merck Completes the Acquisition of Millipore 95

9.1.2 Agilent Technologies Completes Acquisition of Varian 95

9.1.3 Inverness Medical Innovations (Alere Inc.) Acquires 78.13% Stake in Standard Diagnostics 96

9.1.4 Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S. 96

9.2 Key Partnership 97

9.2.1 Abbott Laboratories Enters Into an Agreement with GlaxoSmithKline 97

10 Appendix 98

10.1 Definitions 99

10.1.1 Immunochemistry 99

10.2 Acronyms 102

10.3 Sources 104

10.4 Research Methodology 104

10.5 Primary Research 105

10.6 Models 105

10.7 Forecasts 105

10.8 Expert Panels 106

10.9 GlobalData Consulting 106

10.10 Contact Us 106

10.11 Disclaimer 106

1.1 List of Tables

Table 1: Immunochemistry Market, Global, Revenue ($m), 2003–2010 13

Table 2: Immunochemistry Market, Global, Revenue ($m), 2010–2017 14

Table 3: Laboratory Acquisitions, the US, 2002–2008 17

Table 4: Immunochemistry Market, Global, PE/VC Investments, Volume, 2008-2010 19

Table 5: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2003–2010 23

Table 6: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2010–2017 24

Table 7: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2003–2010 26

Table 8: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2010–2017 27

Table 9: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2003–2010 30

Table 10: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2010–2017 31

Table 11: Endocrinology Tests Market, Global, Revenue ($m), 2003–2010 33

Table 12: Endocrinology Tests Market, Global, Revenue ($m), 2010–2017 34

Table 13: Immunochemistry Analyzers Market, Global, Revenue ($m), 2003–2010 36

Table 14: Immunochemistry Analyzers Market, Global, Revenue ($m), 2010–2017 37

Table 15: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 39

Table 16: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 40

Table 17: Organ Function Assays Market, Global, Revenue ($m), 2003–2010 42

Table 18: Organ Function Assays Market, Global, Revenue ($m), 2010–2017 43

Table 19: Specific Proteins Market, Global, Revenue ($m), 2003–2010 45

Table 20: Specific Proteins Market, Global, Revenue ($m), 2010–2017 46

Table 21: Immunochemistry Market, the US, Revenue ($m), 2003–2010 48

Table 22: Immunochemistry Market, the US, Revenue ($m), 2010–2017 49

Table 23: Immunochemistry Market, Canada, Revenue ($m), 2003–2010 50

Table 24: Immunochemistry Market, Canada, Revenue ($m), 2010–2017 51

Table 25: Immunochemistry Market, the UK, Revenue ($m), 2003–2010 52

Table 26: Immunochemistry Market, the UK, Revenue ($m), 2010–2017 53

Table 27: Immunochemistry Market, Germany, Revenue ($m), 2003–2010 54

Table 28: Immunochemistry Market, Germany, Revenue ($m), 2010–2017 55

Table 29: Immunochemistry Market, France, Revenue ($m), 2003–2010 56

Table 30: Immunochemistry Market, France, Revenue ($m), 2010–2017 57

Table 31: Immunochemistry Market, Italy, Revenue ($m), 2003–2010 58

Table 32: Immunochemistry Market, Italy, Revenue ($m), 2010–2017 59

Table 33: Immunochemistry Market, Spain, Revenue ($m), 2003–2010 60

Table 34: Immunochemistry Market, Spain, Revenue ($m), 2010–2017 61

Table 35: Immunochemistry Market, Japan, Revenue ($m), 2003 – 2010 62

Table 36: Immunochemistry Market, Japan, Revenue ($m), 2010–2017 63

Table 37: Immunochemistry Market, China, Revenue ($m), 2003–2010 64

Table 38: Immunochemistry Market, China, Revenue ($m), 2010–2017 65

Table 39: Immunochemistry Market, India, Revenue ($m), 2003–2010 66

Table 40: Immunochemistry Market, India, Revenue ($m), 2010–2017 67

Table 41: Immunochemistry Market, Australia, Revenue ($m), 2003–2010 68

Table 42: Immunochemistry Market, Australia, Revenue ($m), 2010–2017 69

Table 43: Immunochemistry Market, Brazil, Revenue ($m), 2003–2010 70

Table 44: Immunochemistry Market, Brazil, Revenue ($m), 2010 – 2017 71

Table 45: Immunochemistry Market, Global, Company Shares by Revenues ($m), 2009 72

Table 46: Immunochemistry Portfolio, F. Hoffmann-La Roche Ltd., 2011 73

Table 47: Immunochemistry Pipeline Portfolio, F. Hoffmann-La Roche Ltd., 2011 74

Table 48: Immunochemistry Portfolio, Siemens Healthcare, 2011 77

Table 49: Immunochemistry Pipeline Portfolio, Siemens Healthcare, 2011 78

Table 50: Immunochemistry Portfolio, Abbott Laboratories, 2010 81

Table 51: Immunochemistry Pipeline Portfolio, Abbott Laboratories, 2010 81

Table 52: Immunochemistry Portfolio, Alere Inc., 2011 85

Table 53: Immunochemistry Pipeline Portfolio, Alere Inc., 2011 85

Table 54: PROGENSA PCA3 Assay , Product Status, 2011 88

Table 55: PROGENSA PCA3 Assay – Molecular Urine Tests for Prostate Cancer 88

Table 56: PROGENSA PCA3 Assay – Clinical Evaluation of the PROGENSA PCA3 Assay in Men With a Previous Negative Biopsy Result 89

Table 57: CertNDx Bladder Cancer Assay, Product Status, 2011 90

Table 58: CertNDx Bladder Cancer Assay – Phase III Study of Bladder Cancer Recurrence Surveillance 90

Table 59: CertNDx Bladder Cancer Assay – A Study On ADAM 12 Cleaving Extracellular Matrix Proteins and Correlate With Cancer Status and Stage 91

Table 60: ADVIA Centaur CP System – UE3 Assay, Product Status, 2011 92

Table 61: Access BPHA Assay, Product Status, 2011 92

Table 62: Dimension Vista 1500 Intelligent Lab System CA 15-3 Assay, Product Status, 2011 93

Table 63: Next Generation FIT for Colorectal Cancer, Product Status, 2011 93

Table 64: RealTime mS9 Colorectal Cancer Test, Product Status, 2011 93

Table 65: TheraScreen K-RAS Mutation Test, Product Status, 2011 94

Table 66: AMIPredict, Product Status, 2011 94

1.2 List of Figures

Figure 1: Immunochemistry Market, Global, Revenue ($m), 2003–2010 13

Figure 2: Immunochemistry Market, Global, Revenue ($m), 2010–2017 14

Figure 3: Laboratory Acquisitions, the US, 2002–2008 16

Figure 4: Immunochemistry Market, Global, PE/VC Investments, Volume, 2008-2010 19

Figure 5: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2003–2010 23

Figure 6: Disease Specific Immunochemistry Market, Global, Revenue ($m), 2010–2017 24

Figure 7: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2003–2010 26

Figure 8: Drugs of Abuse/Toxicology Market, Global, Revenue ($m), 2010–2017 27

Figure 9: Drug Tests, Olympics, 2000–2008 28

Figure 10: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2003–2010 30

Figure 11: Therapeutic Drug Monitoring Market, Global, Revenue ($m), 2010–2017 31

Figure 12: Endocrinology Tests Market, Global, Revenue ($m), 2003–2010 33

Figure 13: Endocrinology Tests Market, Global, Revenue ($m), 2010–2017 34

Figure 14: Immunochemistry Analyzers Market, Global, Revenue ($m), 2003–2010 36

Figure 15: Immunochemistry Analyzers Market, Global, Revenue ($m), 2010–2017 37

Figure 16: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 39

Figure 17: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 40

Figure 18: Organ Function Assays Market, Global, Revenue ($m), 2003–2010 42

Figure 19: Organ Function Assays Market, Global, Revenue ($m), 2010–2017 43

Figure 20: Specific Proteins Market, Global, Revenue ($m), 2003–2010 45

Figure 21: Specific Proteins Market, Global, Revenue ($m), 2010–2017 46

Figure 22: Immunochemistry Market, the US, Revenue ($m), 2003–2010 48

Figure 23: Immunochemistry Market, the US, Revenue ($m), 2010–2017 49

Figure 24: Immunochemistry Market, Canada, Revenue ($m), 2003–2010 50

Figure 25: Immunochemistry Market, Canada, Revenue ($m), 2010–2017 51

Figure 26: Immunochemistry Market, the UK, Revenue ($m), 2003–2010 52

Figure 27: Immunochemistry Market, the UK, Revenue ($m), 2010–2017 53

Figure 28: Immunochemistry Market, Germany, Revenue ($m), 2003–2010 54

Figure 29: Immunochemistry Market, Germany, Revenue ($m), 2010–2017 55

Figure 30: Immunochemistry Market, France, Revenue ($m), 2003–2010 56

Figure 31: Immunochemistry Market, France, Revenue ($m), 2010–2017 57

Figure 32: Immunochemistry Market, Italy, Revenue ($m), 2003–2010 58

Figure 33: Immunochemistry Market, Italy, Revenue ($m), 2010–2017 59

Figure 34: Immunochemistry Market, Spain, Revenue ($m), 2003–2010 60

Figure 35: Immunochemistry Market, Spain, Revenue ($m), 2010–2017 61

Figure 36: Immunochemistry Market, Japan, Revenue ($m), 2003 – 2010 62

Figure 37: Immunochemistry Market, Japan, Revenue ($m), 2010–2017 63

Figure 38: Immunochemistry Market, China, Revenue ($m), 2003–2010 64

Figure 39: Immunochemistry Market, China, Revenue ($m), 2010–2017 65

Figure 40: Immunochemistry Market, India, Revenue ($m), 2003–2010 66

Figure 41: Immunochemistry Market, India, Revenue ($m), 2010–2017 67

Figure 42: Immunochemistry Market, Australia, Revenue ($m), 2003–2010 68

Figure 43: Immunochemistry Market, Australia, Revenue ($m), 2010–2017 69

Figure 44: Immunochemistry Market, Brazil, Revenue ($m), 2003–2010 70

Figure 45: Immunochemistry Market, Brazil, Revenue ($m), 2010 – 2017 71

Figure 46: Immunochemistry Market, Global, Company Shares (%), 2009 72

Figure 47: F. Hoffmann-La Roche Ltd, SWOT Analysis 75

Figure 48: Siemens Healthcare, SWOT Analysis 79

Figure 49: Abbott Laboratories, SWOT Analysis 83

Figure 50: Alere Inc., SWOT Analysis 86F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Abbott Laboratories

Alere Inc.

To order this report:

: Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker